Literature DB >> 17205311

Regional cerebral blood flow abnormalities in patients with primary hyperparathyroidism.

Tevfik Fikret Cermik1, Meryem Kaya, Betül Uğur-Altun, Deniz Bedel, Sakir Berkarda, Omer N Yiğitbaşi.   

Abstract

INTRODUCTION: We assessed the alterations in regional cerebral blood flow (rCBF) in patients with primary hyperparathyroidism (PHP) before parathyroidectomy by semiquantitative analysis of brain single photon emission computed tomography (SPECT) images.
METHODS: Included in this prospective study were 14 patients (mean age 47.6 +/- 10.4 years; 3 male, 11 female) and 10 control subjects (mean age 36.0 +/- 8.5 years, 6 male, 4 female) were SPECT imaging was performed using a dual-headed gamma camera 60-90 min after intravenous administration of 925 MBq Tc-99m HMPAO. The corticocerebellar rCBF ratios were calculated from 52 brain areas and reference lower values (RLVs) were calculated from the rCBF ratios of control subjects. The regional ratios that were below the corresponding RLV were considered abnormal (hypoperfused).
RESULTS: Hypoperfusion was shown in 171 out of 728 regions (23%) and there was a significant correlation between serum calcium, PTH levels and the sum of hypoperfused regions in the patient group (R = 0.75 and P = 0.001, and R = 0.75, P = 0.001, respectively). Significantly reduced rCBF were found in the following cortical regions: bilateral cingulate cortex, superior and inferior frontal cortex, anterior temporal cortex, precentral gyrus, postcentral gyrus and parietal cortex, and right posterior temporal cortex.
CONCLUSION: Our results indicate that alterations in rCBF in patients with PHP can be demonstrated with brain SPECT. The correlation between serum calcium, PTH levels and the sum of hypoperfused regions indicates that there may be a strong relationship between rCBF abnormalities and increased levels of serum calcium and PTH. In addition, the degree of rCBF abnormalities could be determined by brain SPECT in PHP patients with or without psychiatric symptoms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17205311     DOI: 10.1007/s00234-006-0198-5

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  33 in total

Review 1.  Primary hyperparathyroidism.

Authors:  A al Zahrani; M A Levine
Journal:  Lancet       Date:  1997-04-26       Impact factor: 79.321

2.  Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression.

Authors:  K Alptekin; B Degirmenci; B Kivircik; H Durak; B Yemez; E Derebek; Z Tunca
Journal:  Psychiatry Res       Date:  2001-07-01       Impact factor: 3.222

3.  Presence of cerebral parathyroid hormone--responsive adenylcyclase in humans.

Authors:  M G Smits; R A de Abreu; P G Froeling; F J Gabreëls
Journal:  Ann Neurol       Date:  1983-09       Impact factor: 10.422

4.  Central nervous system manifestations of hyperparathyroidism.

Authors:  M G Cogan; C M Covey; A I Arieff; A Wisniewski; O H Clark; V Lazarowitz; W Leach
Journal:  Am J Med       Date:  1978-12       Impact factor: 4.965

5.  Mood disorder and chronic hypercalcemia.

Authors:  R E White; A Pickering; G S Spathis
Journal:  J Psychosom Res       Date:  1996-10       Impact factor: 3.006

6.  Psychiatric morbidity in primary hyperparathyroidism.

Authors:  S J McAllion; C R Paterson
Journal:  Postgrad Med J       Date:  1989-09       Impact factor: 2.401

7.  Brain single photon emission computed tomography findings in depressive pseudodementia patients.

Authors:  Maeng Je Cho; In Kyoon Lyoo; Dong Woo Lee; Jun Soo Kwon; Jae Sung Lee; Dong Soo Lee; June Key Jung; Myung Chul Lee
Journal:  J Affect Disord       Date:  2002-05       Impact factor: 4.839

8.  Surgical correction of primary hyperparathyroidism improves quality of life.

Authors:  R E Burney; K R Jones; M Peterson; B Christy; N W Thompson
Journal:  Surgery       Date:  1998-12       Impact factor: 3.982

9.  Neuropsychologic deficits associated with primary hyperparathyroidism.

Authors:  P J Numann; A J Torppa; A E Blumetti
Journal:  Surgery       Date:  1984-12       Impact factor: 3.982

10.  Assessment of changes in regional cerebral blood flow in patients with major depression using the 99mTc-HMPAO single photon emission tomography method.

Authors:  K M Yazici; O Kapucu; B Erbas; E Varoglu; C Gülec; C F Bekdik
Journal:  Eur J Nucl Med       Date:  1992
View more
  6 in total

Review 1.  Cognitive deficits in primary hyperparathyroidism - what we know and what we do not know: A narrative review.

Authors:  Manju Chandran; Lydia Tan Li Yeh; Mechteld C de Jong; John P Bilezikian; Rajeev Parameswaran
Journal:  Rev Endocr Metab Disord       Date:  2022-08-22       Impact factor: 9.306

Review 2.  Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney Disease.

Authors:  Merita Rroji; Andreja Figurek; Davide Viggiano; Giovambattista Capasso; Goce Spasovski
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

3.  Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms.

Authors:  A Trombetti; E R Christ; C Henzen; G Gold; M Brändle; F R Herrmann; C Torriani; F Triponez; M Kraenzlin; R Rizzoli; C Meier
Journal:  J Endocrinol Invest       Date:  2016-01-07       Impact factor: 4.256

Review 4.  Parathyroid hormone, cognitive function and dementia: a systematic review.

Authors:  Ilianna Lourida; Jo Thompson-Coon; Chris M Dickens; Maya Soni; Elżbieta Kuźma; Katarina Kos; David J Llewellyn
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

5.  Age-related increases in parathyroid hormone may be antecedent to both osteoporosis and dementia.

Authors:  Eric R Braverman; Thomas J H Chen; Amanda L C Chen; Vanessa Arcuri; Mallory M Kerner; Anish Bajaj; Javier Carbajal; Dasha Braverman; B William Downs; Kenneth Blum
Journal:  BMC Endocr Disord       Date:  2009-10-13       Impact factor: 2.763

6.  Cognition and cerebrovascular function in primary hyperparathyroidism before and after parathyroidectomy.

Authors:  M Liu; M Sum; E Cong; I Colon; M Bucovsky; J Williams; A Kepley; J Kuo; J A Lee; R M Lazar; R Marshall; S Silverberg; M D Walker
Journal:  J Endocrinol Invest       Date:  2019-10-16       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.